Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Padua, Italy was replaced with Padova, Italy in the study locations.
    Difference
    0.1%
    Check dated 2026-04-06T02:44:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Naples, Italy was added as a location and Napoli, Italy was removed; the revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T18:16:33.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T04:55:07.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:40.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-05T13:38:23.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Shows a new 'Show glossary' option and minor typographic updates in the Study Record Dates area, including capitalization changes in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new 'Revision: v3.4.0' label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T06:57:41.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.